Bio-Rad Laboratories Net Income 2010-2022 | BIO.B

Bio-Rad Laboratories annual/quarterly net income history and growth rate from 2010 to 2022. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Bio-Rad Laboratories net income for the quarter ending September 30, 2022 was $-0.164B, a 104.18% decline year-over-year.
  • Bio-Rad Laboratories net income for the twelve months ending September 30, 2022 was $-6.035B, a 190.63% decline year-over-year.
  • Bio-Rad Laboratories annual net income for 2021 was $4.246B, a 11.55% increase from 2020.
  • Bio-Rad Laboratories annual net income for 2020 was $3.806B, a 116.43% increase from 2019.
  • Bio-Rad Laboratories annual net income for 2019 was $1.759B, a 381.02% increase from 2018.
Bio-Rad Laboratories Annual Net Income
(Millions of US $)
2021 $4,246
2020 $3,806
2019 $1,759
2018 $366
2017 $122
2016 $26
2015 $109
2014 $89
2013 $78
2012 $165
2011 $179
2010 $185
2009 $145
Bio-Rad Laboratories Quarterly Net Income
(Millions of US $)
2022-09-30 $-164
2022-06-30 $-927
2022-03-31 $-3,370
2021-12-31 $-1,574
2021-09-30 $3,928
2021-06-30 $914
2021-03-31 $977
2020-12-31 $839
2020-09-30 $1,315
2020-06-30 $966
2020-03-31 $686
2019-12-31 $553
2019-09-30 $-259
2019-06-30 $599
2019-03-31 $865
2018-12-31 $-829
2018-09-30 $269
2018-06-30 $268
2018-03-31 $657
2017-12-31 $83
2017-09-30 $22
2017-06-30 $5
2017-03-31 $12
2016-12-31 $-23
2016-09-30 $18
2016-06-30 $18
2016-03-31 $12
2015-12-31 $46
2015-09-30 $17
2015-06-30 $28
2015-03-31 $18
2014-12-31 $39
2014-09-30 $12
2014-06-30 $32
2014-03-31 $7
2013-12-31 $30
2013-09-30 $-7
2013-06-30 $35
2013-03-31 $20
2012-12-31 $43
2012-09-30 $43
2012-06-30 $48
2012-03-31 $31
2011-12-31 $60
2011-09-30 $46
2011-06-30 $40
2011-03-31 $33
2010-12-31 $68
2010-09-30 $45
2010-06-30 $38
2010-03-31 $35
2009-12-31 $38
2009-09-30 $39
2009-06-30 $38
2009-03-31 $30
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.069B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $151.446B 9.24
GSK (GSK) United Kingdom $72.652B 9.59
QIAGEN (QGEN) Netherlands $11.227B 19.16
Ginkgo Bioworks Holdings (DNA) United States $3.880B 0.00
Myovant Sciences (MYOV) United Kingdom $2.615B 0.00
Arcus Biosciences (RCUS) United States $1.620B 24.32
Biohaven (BHVN) United States $1.283B 0.00
Emergent Biosolutions (EBS) United States $0.681B 5.35
ADC Therapeutics SA (ADCT) Switzerland $0.419B 0.00
Ambrx Biopharma (AMAM) United States $0.073B 0.00
Enzo Biochem (ENZ) United States $0.066B 0.00
SQZ Biotechnologies (SQZ) United States $0.023B 0.00
Gelesis Holdings (GLS) United States $0.022B 0.00